We also found increased mutations in CSMD3, a tumor suppressor gene, where mutations have been shown to lead to the enhancement of tumor cell proliferation and metastasis and, consequently, contributing to adverse clinical manifestations [37]. This evidence concerns the gene CSMD3 and neoplasm.